|AHFS/Drugs.com||International Drug Names|
|s.c. injection only, premedication with H1 and H2 antihistamines and beta-receptor agonists for bronchodilation|
|Elimination half-life||2.5 h|
|(what is this?)|
It is a 166 amino acid protein produced by E. coli bacteria into which a gene has been inserted for soluble human stem cell factor. It has a monomeric molecular weight of approximately 18,500 daltons and normally exists as a noncovalently associated dimer. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine retained after expression in E. coli. Because Ancestim is produced in E. coli, it is nonglycosylated. Ancestim is supplied as a sterile, white, preservative-free, lyophilised powder for reconstitution and administration as a subcutaneous (SC) injection and is indicated for use in combination with filgrastim for mobilizing peripheral hematopoietic stem cells for later transplantation in certain cancer patients.
- Amgen press office. Biovitrum Closes Product Acquisition Deal with Amgen Archived July 3, 2012, at the Wayback Machine
- da Silva MG, Pimentel P, Carvalhais A, et al. (2004). "Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection". Bone Marrow Transplant. 34 (8): 683–91. doi:10.1038/sj.bmt.1704602. PMID 15322567.
- [https://web.archive.org/web/20131230232434/http://www.sobi.com/en/Healthcare-Professionals/Products-alphabetical-list/Stemgen/ Archived 2013-12-30 at the Wayback Machine Sobi's StemGen page]]
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|